Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesAdministrative/Operational PolicyBlue Cross Blue Shield - Wisconsin Prior Auth List…
    Ask Trek AI about this page

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    CurrentBlue Cross Blue Shield - WisconsinPolicy GA-BCBS-CM-010005-26-S2925

    Georgia Local Precertification / Prior Authorization List

    Customize your policy alerts

    Sign up for Blue Cross Blue Shield - Wisconsin Policy GA-BCBS-CM-010005-26-S2925 alerts

    Get alerted when Policy GA-BCBS-CM-010005-26-S2925 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    List of services and CPT/PLA codes requiring precertification/prior authorization for specified fully‑insured Georgia members and select ASO members; identifies Carelon Medical Benefits Management as the responsible UM vendor and explains provider verification of eligibility. Excludes BlueCard, Medicare Advantage, Medicaid, Medicare Supplement, and FEP members.

    Policy Summary
    PayerBlue Cross Blue Shield - Wisconsin
    PolicyGeorgia Local Precertification / Prior Authorization List
    Policy CodePolicy GA-BCBS-CM-010005-26-S2925
    Change TypeRoutine update — no material coverage changes
    Effective DateApr 1, 2026
    Last ReviewApr 1, 2026
    Next Review Date
    Key ActionProviders must verify member eligibility and obtain precertification via the Anthem website or call the number on the member ID card; submit requests to Carelon at www.providerportal.com or 866-714-1103.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    Georgia onlyGeographic applicability
    CarelonResponsible party
    Preapproval requiredDenial risk if not preapproved
    20+
    Procedure codes listed (excerpt)
    2026-04-01Document effective

    Coverage Criteria and Mappings

    Precertification requirements

    Precertification is required for the listed services for covered Georgia members; providers must verify eligibility and obtain preapproval per the Carelon process.

    Precertification / prior authorization is required for the services and CPT/PLA codes listed in this document for applicable Georgia members (except emergencies).

    Providers must verify member eligibility and benefits via the Anthem website or the number on the back of the member ID card; failure to obtain preapproval will result in denial of reimbursement.

    Carelon Medical Benefits Management is the responsible utilization management vendor for the listed programs and will manage review and preapproval for assigned codes.

    Submit requests online at www.providerportal.com (select GA) or call Carelon toll-free at 866-714-1103, Monday–Friday, 8 a.m.–6 p.m. ET.

    Application of specific clinical criteria and guideline references (Carelon criteria and MCG/CG/GRG/ISC/RFC references shown alongside codes) will determine authorization decisions for each code.

    Mapped coverage guidance by code

    Coverage determinations for listed procedure codes are guided by the named responsible party (Carelon MBM) and the associated MCG/Carelon guideline references.

    Code 22610 (Arthrodesis, posterior or posterolateral technique, single level; thoracic) — Responsible party: Carelon Medical Benefits Management; Criteria/Guideline: Carelon Spine Surgery; MCG GRG: SG-MS (Musculoskeletal Surgery GRG).
    Code 22843/22844/22845 (Posterior/Anterior segmental instrumentation codes) — Responsible party: Carelon Medical Benefits Management; Criteria/Guideline: Carelon Spine Surgery; MCG ISC: P-1056 and related RRG references.
    Cardiac imaging codes (e.g., 75557, 75559, 75561, 75563, 75571–75573) — Responsible party: Carelon Medical Benefits Management; Criteria/Guideline: Carelon 'Imaging of the Heart' (Cardiac MRI/CT).

    Authorization criteria linkage (descriptive)

    Codes listed for joint and small joint surgery are reviewed using Carelon and MCG criteria that include level-of-care and site-of-care considerations.

    Apply Carelon Joint Surgery criteria and MCG guidelines (e.g., 'Joint Surgery', 'Level of Care for Surgical Procedures') to authorization decisions for major joint procedures (hip, knee, shoulder).
    Carelon Medical Benefits Management is the responsible party to conduct review and determine prior authorization for the joint and small joint surgery codes listed.

    Codes with referenced clinical/operational guidelines

    Listed procedure codes are linked to specific clinical/operational guideline references that inform authorization and site-of-care determinations.

    Arthroscopy and joint surgery codes (examples: shoulder, hip, knee arthroscopy codes) — linked to Carelon Joint Surgery criteria and MCG guidelines; site-of-care and level-of-care guidance apply.
    Carelon is responsible for review of the listed codes and will apply the referenced guideline(s) provided for each procedure entry.

    Authorization requirements for listed procedures

    Prior authorization is required for the CPT codes listed; Carelon MBM applies the referenced Carelon and MCG criteria during review.

    Prior authorization required for listed surgical and interventional procedures; review performed by Carelon Medical Benefits Management per referenced Carelon/MCG guidelines.
    Examples include spine surgery, interventional pain, and select brachytherapy/prostate procedures; apply the named MCG/CG references indicated with each code.

    Coverage with criteria

    Coverage and authorization decisions for the CPT codes in this segment are determined by applying the listed Carelon and MCG criteria sets.

    Each CPT/procedure code in the listed segments is evaluated against Carelon Medical Benefits Management criteria and the specific MCG guideline references (ISC/RFC/GRG/CG-SURG) provided per code.
    Carelon will issue prior authorization determinations based on applicability of clinical criteria and level/site-of-care guidance for the specific code and clinical indication.

    Authorization mapping for listed advanced imaging codes

    Advanced imaging codes are reviewed by Carelon and mapped to internal imaging criteria (Site of Care for Advanced Imaging; Imaging by body region).

    Grouped brain/chest/abdomen/spine/extremity imaging CPT codes (e.g., 70545–70555, 71250–71275, 72156–72198, 74150–74185, 73200–73725) — Responsible party: Carelon Medical Benefits Management; Criteria: Site of Care for Advanced Imaging and body-region imaging guidelines (Imaging of the Brain, Chest, Spine, Abdomen and Pelvis, Extremities, Heart).
    Prior authorization is expected where the Carelon imaging criteria or MCG references indicate review is required for site-of-care or clinical appropriateness.

    Example criteria mapping (cardiac imaging)

    Cardiac imaging codes are assigned to Carelon and evaluated under the 'Imaging of the Heart' criteria.

    Cardiac MRI/CT and myocardial imaging CPTs (examples: 75557, 75559, 75561, 75563, 75571–75573, 78429–78433) — Responsible party: Carelon Medical Benefits Management; Criteria/Guideline: Carelon 'Imaging of the Heart'.
    Authorization for these cardiac imaging codes is based on the Carelon 'Imaging of the Heart' guideline and related clinical indications documented at the time of request.

    Code → Carelon criteria mappings

    Each genetic test code is mapped to a Carelon criteria/guideline category (examples below).

    Code 81161 — Criteria: Carrier Screening in the Reproductive Setting; Genetic Testing for Inherited Conditions — action: refer to Carelon guideline for prior authorization.
    Code 81162 — Criteria: Hereditary Cancer Testing; Somatic Tumor Testing — action: refer to Carelon guideline for prior authorization.
    Code 81228 — Criteria: Chromosomal Microarray Analysis; Genetic Testing for Inherited Conditions — action: refer to Carelon guideline for prior authorization.
    Code 81225/81226 — Criteria: Pharmacogenetic Testing (CYP2C19, CYP2D6) — action: refer to Carelon Pharmacogenetic Testing criteria for prior authorization.

    Mapping to Carelon review guidelines

    Codes reference specific Carelon guideline categories for the testing type; consult the Carelon guideline for clinical coverage criteria.

    Each listed CPT code for genetic testing is linked to a Carelon guideline category (examples: Carrier Screening in the Reproductive Setting; Genetic Testing for Inherited Conditions; Somatic Tumor Testing; Hereditary Cancer Testing; Pharmacogenetic Testing).

    Specific clinical coverage criteria and indication requirements are contained in the referenced Carelon guideline.

    Association of codes with Carelon criteria

    Pharmacogenetic, molecular pathology, and panel codes are associated with Carelon criteria specific to test complexity and panel content.

    Pharmacogenetic test codes (e.g., 81335, TPMT; 81381 and related codes) — Criteria: Carelon Pharmacogenetic Testing — action: review per Carelon pharmacogenetic criteria.
    Molecular pathology procedure level codes (81400–81408 etc.) — Criteria: Carelon Molecular Pathology levels (Level 1–9) — action: apply Carelon molecular pathology criteria for authorization.
    Genomic panel codes (e.g., 81410, 81418, 81430, 81455–81459) — Criteria: Carelon Somatic Tumor Testing or specified panel guidance; note minimum gene-count requirements where indicated in Carelon criteria.

    Linked internal guideline references

    The listed codes are associated with the following Carelon internal guideline references — consult these for authorization rules.

    Guideline 'Somatic Tumor Testing' — owner: Carelon Medical Benefits Management — description: referenced for oncology molecular and expression assay CPT codes; consult for indication-specific authorization criteria (e.g., 81455–81459, 0048U).
    Guideline 'Genetic Liquid Biopsy in the Management of Cancer and Cancer Surveillance' — owner: Carelon Medical Benefits Management — description: referenced for cell-free/plasma genomic tests (e.g., 81460, 81462–81464, 0229U).
    Guideline 'Imaging of the Heart' — owner: Carelon Medical Benefits Management — description: referenced for echocardiography and cardiac imaging codes (e.g., 93303–93317, 93350–93351, 75557–75563).

    Per-code prior authorization guidance (excerpt)

    Per-code prior authorization guidance: each code is reviewed by Carelon with the responsible guideline noted.

    Code 93315 — Responsible party: Carelon Medical Benefits Management; Guideline: Imaging of the Heart — action: prior authorization per Carelon criteria.
    Code 93454 — Responsible party: Carelon Medical Benefits Management; Guideline: Diagnostic Coronary Angiography; MCG Guidelines — action: prior authorization per referenced MCG/Carelon criteria.
    Code 93650 — Responsible party: Carelon Medical Benefits Management; Guideline: Transcatheter Ablation for Management of Atrial Fibrillation; MCG — action: prior authorization per referenced MCG/Carelon criteria.
    Code 97110 and related PT/OT/SLP procedure codes — Responsible party: Carelon Medical Benefits Management; Guideline: Physical Therapy, Occupational Therapy, Speech Therapy, and Site of Care — action: prior authorization expected per Carelon PT/OT/SLP guidance.

    Therapy-related coverage mapping

    Physical, occupational and speech therapy CPT codes are managed under Carelon therapy criteria and site-of-care guidance.

    Therapy procedure codes (examples: 97110, 97112, 97113, 97116, 97124, 97129, 97161–97163) — Responsible party: Carelon Medical Benefits Management; Criteria/Guideline: Physical Therapy, Occupational Therapy, Speech Therapy, Site of Care for Physical/Occupational/Speech Therapies; effect: prior authorization expected or managed by Carelon.

    Sedation and HBOT coverage mapping

    Sedation and hyperbaric oxygen therapy codes reference external CG-MED criteria.

    Moderate sedation initial units (99151, 99152, 99155, 99156) — Responsible party: Carelon Medical Benefits Management; Criteria/Guideline: CG-MED-21 and CG-MED-41 — action: refer to the listed CG-MED criteria for authorization.
    Hyperbaric oxygen therapy supervision (99183) — Responsible party: Carelon Medical Benefits Management; Criteria/Guideline: CG-MED-73 — action: refer to CG-MED-73 for coverage rules.

    Genetic/somatic testing coverage mapping

    PLA/proprietary laboratory codes are assigned to Carelon and mapped to genetic/somatic testing guideline categories.

    Selected PLA/Proprietary lab codes (examples: 0001U, 0005U, 0006M, 0011M, 0048U, 0055U, 0069U) — Responsible party: Carelon Medical Benefits Management; Criteria/Guideline: Genetic Testing for Inherited Conditions; Somatic Tumor Testing; Genetic Liquid Biopsy; Predictive and Prognostic Polygenic Testing; Pharmacogenetic Testing — effect: prior authorization or application of clinical criteria applies.
    High-complexity oncology PLA codes (e.g., 0048U) and large panel tests are reviewed under Carelon Somatic Tumor Testing criteria; consult Carelon guideline for test-specific authorization requirements.

    Code-to-guideline assignments

    Codes across the genetic and molecular testing sections are assigned to Carelon with named guideline categories for review.

    Carelon Medical Benefits Management is assigned as the reviewer for the genetic/molecular testing codes listed; guideline examples applied include: Somatic Tumor Testing; Hereditary Cancer Testing; Carrier Screening in the Reproductive Setting; Pharmacogenetic Testing; Genetic Liquid Biopsy; Whole Exome/Genome Sequencing; Predictive and Prognostic Polygenic Testing; and MCG where surgical codes are included.
    Specific code-to-guideline mapping and any panel-size minimums are noted in the code entries and must be consulted in the referenced Carelon guideline when requesting authorization.

    Representative CPT/HCPCS Codes and Coding Notes

    Sample CPT codes requiring review by CarelonCPTCovered
    00170Anesthesia for intraoral procedures, including biopsy; not otherwise specified.
    01941Anesthesia for percutaneous image-guided neuromodulation or intravertebral procedures (eg, kyphoplasty, vertebroplasty) on the spine or spinal cord; cervical or thoracic.
    22510Percutaneous vertebroplasty, 1 vertebral body, unilateral or bilateral injection, inclusive of all imaging, cervicothoracic.
    22514Percutaneous vertebral augmentation (kyphoplasty), 1 vertebral body, lumbar.
    22630Arthrodesis, posterior interbody technique, including laminectomy and/or discectomy to prepare interspace (other than for decompression), single interspace, lumbar.
    Lumbar/cervical fusion codesCPTCovered
    22610Arthrodesis, posterior or posterolateral technique, single level; thoracic (with lateral transverse technique, when performed).
    22612Arthrodesis, posterior or posterolateral technique, single level; lumbar (with lateral transverse technique, when performed).
    22630Arthrodesis, posterior interbody technique, including laminectomy and/or discectomy to prepare interspace (other than for decompression), single interspace, lumbar.
    Spinal instrumentation codesCPTCovered
    22842Posterior segmental instrumentation; 3 to 6 vertebral segments.
    22845Anterior instrumentation; 2 to 3 vertebral segments.
    Shoulder arthroplasty codesCPTCovered
    23470Arthroplasty, glenohumeral joint; hemiarthroplasty.
    23472Arthroplasty, glenohumeral joint; total shoulder (glenoid and proximal humeral replacement).
    Knee joint surgery codes (examples)CPT
    27332-27416Various knee arthrotomy/arthroplasty/meniscal and ligament repair codes enumerated in the list.
    Ankle/foot surgery codesCPT
    27702-28312Ankle and foot surgical procedure codes (arthroplasty, arthrodesis, bunionectomy, osteotomy).
    Arthroscopy procedure codesCPT
    29800-29881Arthroscopy codes for TMJ, shoulder, hip, and knee (diagnostic and surgical).
    Knee arthroscopy codesCPT
    29871Arthroscopy, knee; for infection, lavage and drainage.
    29873Arthroscopy, knee; with lateral release.
    29874Arthroscopy, knee; removal of loose body or foreign body.
    Venous procedure codesCPT
    36465Injection of non-compounded foam sclerosant; single incompetent extremity truncal vein.
    36475Endovenous ablation therapy, radiofrequency; first vein treated.
    Pacemaker/ICD codesCPT
    33206Insertion of new or replacement of permanent pacemaker with transvenous electrode(s); atrial.
    33207Insertion of new or replacement of permanent pacemaker with transvenous electrode(s); ventricular.
    Spine surgery codes (examples)CPTCovered
    63001Laminectomy with exploration and/or decompression of spinal cord and/or cauda equina, without facetectomy, 1-2 vertebral segments; cervical.
    63005Laminectomy with exploration and/or decompression; lumbar, 1-2 segments (except spondylolisthesis).
    63020Laminotomy with decompression; cervical, 1 interspace.
    Gynecologic brachytherapy codesCPTCovered
    57155Insertion of uterine tandem and/or vaginal ovoids for clinical brachytherapy.
    57156Insertion of a vaginal radiation afterloading apparatus for clinical brachytherapy.
    Representative CPT groups in this segmentCPT
    63250Laminectomy related codes and other spine surgery codes listed.
    63620Stereotactic radiosurgery; 1 spinal lesion.
    64479Transforaminal epidural injection, cervical or thoracic, single level.
    64561Percutaneous implantation of neurostimulator electrode array; sacral nerve.
    64629Thermal destruction of basivertebral nerve (each additional vertebral body).
    65778Placement of amniotic membrane on ocular surface; without sutures.
    70450CT head without contrast.
    70551MRI brain without contrast.
    Grouped brain and chest imaging codesCPT
    70545-70555Head/brain MRI and MRA series (with/without contrast, functional MRI variants).
    71250-71275CT thorax series including CTA.
    Abdomen/pelvis imaging codesCPT
    74150-74183CT/MR abdomen and pelvis series including CTA.
    74261-74263CT colonography diagnostic/screening.
    Cardiac imaging codesCPT
    75557-75563Cardiac MRI (with/without contrast, stress variants).
    75571-75573Cardiac CT (calcium scoring, contrast CT including congenital evaluations).
    Representative imaging and genetic testing codesCPT
    75557Cardiac MRI for morphology and function without contrast.
    78429Myocardial PET metabolic evaluation with CT transmission scan.
    81162BRCA1/BRCA2 full sequence and duplication/deletion analysis.
    Selected representative genetic test CPT/HCPCS codesCPT
    81161BRCA1/BRCA2 full sequence and full duplication/deletion analysis.
    81162BRCA1/BRCA2 full sequence and full duplication/deletion analysis (alternate listing).
    81163BRCA1/BRCA2 full sequence analysis.
    81216BRCA2 full sequence analysis.
    81210BRAF V600 variant.
    81228Cytogenomic genome-wide microarray (CGH).
    81225CYP2C19 common variants (pharmacogenetic).
    81226CYP2D6 common variants (pharmacogenetic).
    Selected hereditary/carrier testing CPT codes (partial list)CPT
    81252GJB2 gene analysis; full gene sequence.
    81253GJB2 gene analysis; known familial variants.
    81254GJB6 gene analysis; common variants (eg, 309kb and 232kb deletions).
    81255HEXA gene analysis; common variants (Tay-Sachs).
    81256HFE gene analysis; common variants (eg, C282Y, H63D).
    Selected somatic tumor / other molecular codes (partial list)CPT
    81261IGH@ gene rearrangement analysis; amplified methodology.
    81262IGH@ gene rearrangement analysis; direct probe methodology.
    81263IGH@ variable region somatic mutation.
    81270JAK2 V617F variant analysis.
    81271HTT (Huntington) evaluation to detect expanded alleles.
    Additional somatic and pharmacogenetic CPT codes (partial list)CPT
    81276KRAS additional variants; cytogenomic neoplasia microarray.
    81277Cytogenomic neoplasia (genome-wide) microarray analysis.
    81283IFNL3 gene analysis, rs12979860 variant (pharmacogenetic).
    81284FXN expanded allele detection (Friedreich ataxia).
    81287MGMT promoter methylation analysis.
    Hereditary cancer and pharmacogenetic codes (partial list)CPT
    81292MLH1 full sequence analysis.
    81293MLH1 known familial variants.
    81295MSH2 full sequence analysis.
    81298MSH6 full sequence analysis.
    81306NUDT15 common variants (pharmacogenetic).
    Hereditary cancer / genetic condition codes (partial list)CPT
    81307PALB2 full gene sequence.
    81309PIK3CA targeted sequence analysis.
    81313PCA3/KLK3 ratio (predictive/prognostic polygenic testing).
    81321PTEN full sequence analysis.
    81324PMP22 duplication/deletion analysis.
    Carrier screening, pharmacogenetic, and hereditary codes (partial list)CPT
    81329SMN1 dosage/deletion analysis (includes SMN2) - carrier testing.
    81330SMPD1 common variants (Niemann-Pick Type A).
    81331SNRPN/UBE3A methylation analysis (Prader-Willi/Angelman).
    81334RUNX1 targeted sequence analysis (familial AML/platelet disorder).
    81335TPMT common variants (drug metabolism).
    Additional genetic testing and rearrangement codes (partial list)CPT
    81336SMN1 full gene sequence.
    81340TRB@ gene rearrangement analysis; amplified methodology.
    81341TRB@ gene rearrangement analysis; direct probe methodology.
    81342TRG@ gene rearrangement analysis.
    81343PPP2R2B evaluation to detect expanded alleles.
    Pharmacogenetic testing codesCPTCovered
    81335TPMT gene analysis, common variants.
    81350UGT1A1 common variants.
    81355VKORC1 common variants (warfarin metabolism).
    Hereditary cancer and cardiomyopathy panelsCPTCovered
    81432Hereditary breast cancer-related disorder panel (≥10 genes incl. BRCA1/2).
    81435Hereditary colon cancer disorders panel (≥10 genes).
    81439Hereditary cardiomyopathy panel (≥5 genes).
    High-complexity genomic panelsCPT
    81455Solid organ or hematolymphoid neoplasm panel, 51+ genes, DNA or combined DNA/RNA analysis.
    81456Solid organ or hematolymphoid neoplasm panel, 51+ genes, RNA analysis.
    81460Whole mitochondrial genome sequencing with heteroplasmy detection.
    Oncology expression assaysCPT
    81519Breast oncology, 21-gene RT-PCR, recurrence score.
    81521Breast oncology, 70-gene microarray, metastasis risk index.
    81540Tumor of unknown origin, 92-gene RT-PCR classifier.
    Reproductive services and storageCPT
    89337Cryopreservation, mature oocyte(s).
    89344Storage (per year); reproductive tissue.
    Cardiac procedures and imagingCPT
    92920Percutaneous transluminal coronary angioplasty; single major coronary artery or branch.
    93306Transthoracic echocardiography, complete with spectral and color Doppler.
    Representative codes listed in this partCPT
    93315Transesophageal echocardiography for congenital cardiac anomalies; includes probe placement, image acquisition, interpretation and report.
    93454Catheter placement in coronary artery(s) for coronary angiography; imaging supervision and interpretation.
    93650Intracardiac catheter ablation of atrioventricular node function/conduction for creation of complete heart block.
    95810Polysomnography; age 6 years or older, sleep staging with 4+ additional parameters, attended by a technologist.
    97010Application of a modality to 1 or more areas; hot or cold packs.
    Therapy procedure CPTsCPTCovered
    97110Therapeutic exercises, each 15 minutes.
    97112Neuromuscular reeducation, each 15 minutes.
    97113Aquatic therapy with therapeutic exercises.
    Moderate sedation CPTsCPTCovered
    99151Moderate sedation, initial 15 minutes, patient younger than 5 years.
    99156Moderate sedation, initial 15 minutes, patient >=5 years.
    PLA/ Proprietary lab codesmixed
    0001URed blood cell antigen typing, DNA (35 antigens).
    0037UTargeted genomic sequence analysis, solid organ neoplasm (324 genes).
    0048UTargeted sequencing of 468 cancer-associated genes.
    Guideline linkage — MCG and Carelon criteria referenced for authorization decisions

    What Providers Must Do

    Prior Authorization

    Precertification / Preapproval Process

    Verify member eligibility and benefits via the Anthem provider site or the phone number on the member's ID card before submitting a request. Precertification/prior authorization determinations are based on the member's benefit plan and eligibility at time of review. Except for emergencies, services listed in this document that are rendered without required preapproval are subject to denial of reimbursement.

    • Verify eligibility on Anthem website or call member ID card phone number
    • Preapproval is benefit-plan dependent and based on eligibility at time of review
    • Failure to obtain preapproval (except emergencies) may result in denial
    Denial Risk

    Consequence of No Preapproval

    If required preapproval is not obtained prior to rendering designated services (unless the service is an emergency), claims for those services may be denied. Providers will be notified during the precertification check if preapproval is required for the member.

    Definitions and Glossary

    Carelon — defined term for Carelon Medical Benefits Management
    Defined termCarelon = Carelon Medical Benefits Management, the utilization management vendor referenced throughout the document
    RoleProvides specialty benefits management and precertification services for listed programs (eg, Advanced Imaging, Genetic Testing, Radiation Therapy)
    Provider contactSubmit requests via www.providerportal.com (select GA) or call 866-714-1103
    Scope population — local fully-insured Anthem BCBS members in Georgia and select ASO members
    PopulationLocal fully‑insured Anthem Blue Cross and Blue Shield members in Georgia and select self‑insured (ASO) members with purchased programs
    ExclusionsDoes not apply to BlueCard, Medicare Advantage, Medicaid, Medicare Supplement, or FEP members

    Policy Revision History

    Policy Summary
    PayerBlue Cross Blue Shield - Wisconsin
    PolicyGeorgia Local Precertification / Prior Authorization List
    Policy CodePolicy GA-BCBS-CM-010005-26-S2925
    Change TypeRoutine update — no material coverage changes
    Effective DateApr 1, 2026
    Last ReviewApr 1, 2026
    Next Review Date
    Key ActionProviders must verify member eligibility and obtain precertification via the Anthem website or call the number on the member ID card; submit requests to Carelon at www.providerportal.com or 866-714-1103.
    SourceLink
    On This Page
    Coverage Criteria and MappingsRepresentative CPT/HCPCS Codes and Coding NotesWhat Providers Must DoDefinitions and GlossaryPolicy Revision History
    Primary guideline sourcesMCG Guidelines and Carelon Medical Benefits Management criteria (Level of Care; Site of Care; specialty GRG/ISC/RRG references)
    Use for authorizationAuthorization decisions reference MCG guidance (eg, ISC/RFC/GRG identifiers) alongside Carelon criteria for procedure-specific review
    Specialty GRGs referencedExamples include Musculoskeletal Surgery (SG-MS), Cardiovascular (SG-CVS), Thoracic Surgery (SG-TS)
    Review by Carelon / MCG — prior authorization required per listed guideline references
    Prior authorization requirementPrior authorization required per the listed Carelon or MCG guideline reference for the CPT codes shown
    Responsible reviewerCarelon Medical Benefits Management conducts the prior authorization review
    Notification to providerProvider is notified upon precertification request if preapproval is required for the member
    Per-procedure review — each CPT/procedure reviewed against Carelon/MCG criteria
    Per-procedure evaluationEach CPT/procedure listed is reviewed against the relevant Carelon criteria and referenced MCG guideline prior to authorization
    Code-specific mappingIndividual codes include explicit Criteria/Guideline assignments (eg, Imaging of the Heart; Diagnostic Coronary Angiography) used in review
    ActionApply the named Carelon guideline for clinical coverage decisions on a per-procedure basis
    Code coverage tied to Carelon criteria — coverage determined per listed Carelon MBM criteria/guidelines
    Coverage determination basisCoverage for each code is determined by the associated Carelon Medical Benefits Management criteria/guidelines listed with the code
    Genetic and molecular codesCodes mapped to categories such as Hereditary Cancer Testing, Somatic Tumor Testing, Pharmacogenetic Testing are reviewed under Carelon criteria
    Imaging and procedure codesAdvanced imaging and surgical codes reference Site of Care and MCG guidelines for coverage decisions
    None specified in this segment — placeholder note
    Segment noteNo specific thresholds or values are specified in this document segment
    ImplicationRefer to individual code entries or named Carelon/MCG guidelines for detailed coverage criteria
    Responsible party reminderCarelon Medical Benefits Management remains the assigned reviewer for codes in this segment
    Minimum genes required for panel codes — examples of gene-count thresholds for panels
    Example panel minimums81410 panels must include sequencing of at least 9 genes
    Pharmacogenetic panel example81418 panels must include testing of at least 6 genes (including CYP2C19 and CYP2D6)
    Large panel example81430 hearing-loss panels must include sequencing of at least 60 genes
    Minimum genes required (example) — specific panels must include sequencing of at least 60 genes
    60-gene requirement (examples)81470/81471 panels must include sequencing/analysis of at least 60 genes (eg, ARX, ATRX, CDKL5, FMR1, MECP2, etc.)
    Applicable codes81470 (sequence panel) and 81471 (duplication/deletion analysis panels) for X-linked intellectual disability
    Responsible partyCarelon Medical Benefits Management applies the Genetic Testing for Inherited Conditions guideline to these panels
    Typical face-to-face time — PT evaluation time mappings (97161/97162/97163)
    97161 (low complexity)Typically 20 minutes face-to-face; history with no personal factors/comorbidities and exams addressing 1–2 elements; low complexity decision making
    97162 (moderate complexity)Typically 30 minutes face-to-face; history with 1–2 personal factors/comorbidities and exams addressing 3+ elements; moderate complexity decision making
    97163 (high complexity)Typically 45 minutes face-to-face; history with 3+ personal factors/comorbidities and exams addressing 4+ elements; high complexity decision making
    • Non-emergency services without preapproval are at risk of denial
    • Providers will be notified when requesting precertification if preapproval is required
    Note

    Responsible UM Vendor — Carelon

    Carelon Medical Benefits Management is the designated utilization management (UM) vendor for the listed categories. Determine whether a Georgia member requires preapproval by using the Medical Policy/Clinical UM Guidelines and Preapproval Requirements link on the provider website or by contacting Carelon via www.providerportal.com (select GA) or toll-free at 866-714-1103, Mon–Fri 8 a.m.–6 p.m. ET.

    • Carelon manages Advanced Imaging, Musculoskeletal, Genetic Testing, Radiation Therapy, Cardiovascular services, Rehabilitative and Sleep services, Fertility, Oncology and other listed programs
    • Submit preapproval requests at www.providerportal.com (select GA) or call 866-714-1103
    Prior Authorization

    Spine Surgery Prior Authorization Linkage

    Spine surgery and spinal instrumentation CPT codes listed in this document are assigned to Carelon for prior authorization review and are evaluated using Carelon Spine Surgery medical necessity criteria and referenced MCG spine surgery/GRG guidelines. Obtain prior authorization from Carelon for procedures such as arthrodesis/fusion (e.g., 22600, 22610, 22612, 22614, 22630), laminectomy/discectomy (e.g., 62380, 63001, 63250, 63267, 63005), neurostimulator implantation/revision (e.g., 63655, 63685), and instrumentation codes (e.g., 22843–22846).

    • Spine surgery codes linked to Carelon Spine Surgery criteria and MCG GRG/ISC references
    • Spinal instrumentation codes assigned to Carelon and linked to pediatric and scoliosis instrumentation guidelines (e.g., 22843–22846)
    • Prior authorization required for spine procedures unless emergency
    Prior Authorization

    Joint Surgery Prior Authorization Linkage

    Shoulder, hip, knee, small joint, and other joint surgery CPT codes in the list are managed by Carelon and evaluated using Carelon Joint Surgery criteria, Site/Level of Care surgical procedures guidance and applicable MCG Joint Surgery guidelines. This includes arthroplasty, arthrotomy, ligament/meniscal repairs, and related procedures.

    • Joint surgery codes (shoulder, hip, knee, small joints) require prior authorization through Carelon and reference MCG Joint Surgery guidelines
    • Examples include rotator cuff repair and shoulder arthroplasty (23410, 23412, 23470–23474), hip arthroplasty/conversion (27130, 27132), knee arthrotomy/repair (27333, 27403, 27405–27416), and small joint/foot codes (28289, 28291, 28292, 28295, 28306–28312)
    Prior Authorization

    Knee Arthroscopy and Joint Surgery Codes

    Specific joint and knee procedure codes (including arthroscopy and arthrotomy codes) are subject to Carelon review and prior authorization. Arthroscopy codes are reviewed with attention to site-of-care and level-of-care considerations.

    • Knee arthroscopy and related joint surgery codes (e.g., 29873–29876, 27333, 27403) are reviewed by Carelon
    • Arthroscopy codes include site-of-care/level-of-care review and may require local precertification
    Prior Authorization

    Venous Insufficiency / Varicose Vein Procedures

    Venous insufficiency and varicose vein procedures (including endovenous ablation, mechanochemical, radiofrequency, laser, cyanoacrylate adhesive, and related codes such as 36471, 36473, 36475, 36478, 36482) require prior authorization by Carelon and are reviewed under venous treatment guidelines (Treatment of Varicose Veins and Superficial Venous Insufficiency).

    • Endovenous ablation and related venous procedure codes (36471, 36473, 36475, 36478, 36482) assigned to Carelon
    • Carelon applies venous insufficiency treatment guidelines and MCG references
    Note

    Selected Reviewed Procedure Codes (Non‑Exhaustive)

    The CPT code lists in this document are examples (non‑exhaustive) of procedures that require precertification/prior authorization and are assigned to Carelon. Providers must check member-specific requirements and submit requests to Carelon for review prior to performing these services.

    • Document contains many reviewed procedure codes across specialties (surgical, imaging, genetic, cardiac, oncology, rehab, etc.)
    • Providers should not assume coverage — verify and obtain prior authorization for listed services
    Prior Authorization

    Spine Imaging Codes

    Spine advanced imaging (CT/MR/CTA of spine regions) and spine-related imaging codes (e.g., 72125–72133, 72141, 72127–72133) are assigned to Carelon and reviewed using the Imaging of the Spine and Site of Care for Advanced Imaging criteria. Obtain prior authorization from Carelon when required.

    • CT/MR spine codes (72125–72133, 72141, etc.) mapped to Carelon Imaging of the Spine criteria
    • Prior authorization may be required for advanced spine imaging per Site of Care guidance
    Prior Authorization

    Abdomen / Pelvis / Pelvis Angiography Codes

    Computed tomography and magnetic resonance imaging of the abdomen and pelvis (including CT/CTA/CTA abdomen & pelvis codes 74150–74178, 72192–72198 and CTA/angiography codes such as 74174/74175) are assigned to Carelon for review under Imaging of the Abdomen and Pelvis and Site of Care for Advanced Imaging. Preauthorization is required when indicated by member benefit and Carelon guidelines.

    • Abdomen/pelvis CT and MR codes (74150–74183, 74174–74178) mapped to Carelon Imaging of the Abdomen/Pelvis criteria
    • CTA/angiography codes linked to vascular imaging and Site of Care for Advanced Imaging
    Prior Authorization

    Extremities Imaging Codes

    Extremity imaging (CT/MR/MRA of upper and lower extremities, joints, and angiography) such as codes 73200–73225, 73700–73725, 73718–73723 and related angiographic codes are reviewed by Carelon under Imaging of the Extremities and Site of Care for Advanced Imaging. Obtain prior authorization when required by Carelon.

    • Upper extremity imaging codes (73200–73225) and lower extremity imaging codes (73700–73725) assigned to Carelon
    • Extremity MR arthrograms/joint imaging mapped to Oncologic Imaging and Site of Care for Advanced Imaging
    Prior Authorization

    Cardiac Imaging (MRI/CT/FFR CT) Authorization

    Cardiac MRI and CT imaging codes (e.g., 75557–75563, 75571–75574, 75580) including coronary CTA, cardiac morphology/function studies, and FFR-CT (75580) are assigned to Carelon and reviewed using the Imaging of the Heart guideline. Prior authorization is required when indicated.

    • Cardiac MRI/CT codes (75557, 75559, 75561, 75563) mapped to Imaging of the Heart
    • Coronary CTA and FFR-CT codes (75571–75574, 75580) require Carelon review
    Prior Authorization

    Advanced Imaging and Ultrasound Authorization

    Advanced imaging modalities (MRI/MRS, MR spectroscopy, MR elastography), specialized ultrasound (e.g., transrectal ultrasound for brachytherapy planning 76873) and other advanced imaging codes (76390, 76391, 76873, 76965, 77046–77049) are assigned to Carelon and reviewed under appropriate Imaging or Radiation Therapy guidelines.

    • Advanced imaging and spectroscopy codes (76390, 76391) mapped to brain/abdomen imaging criteria
    • Ultrasound codes for therapy planning (76873, 76965) assigned to Carelon and linked to Radiation Therapy criteria
    Prior Authorization

    PET Imaging Authorization

    PET imaging (brain, myocardial, whole‑body, limited or with CT) CPT codes (e.g., 78429–78432, 78491–78492, 78608–78609, 78811–78816, 78814–78816, 78608) are assigned to Carelon and reviewed using Imaging of the Heart/Brain and Oncologic Imaging criteria. Prior authorization is required for PET studies when indicated by member benefits and Carelon guidelines.

    • Myocardial and brain PET codes (78429–78432, 78608–78609) assigned to Carelon
    • Whole‑body and region PET/PET‑CT codes (78811–78816) require Carelon review
    Prior Authorization

    Genetic Testing Codes and Associated Criteria

    Genetic testing codes, including single‑gene tests, molecular pathology Level 1–9 codes (81400–81408), targeted gene analyses (e.g., 81120–81121, 81161, 81162–81167), and large genomic panels (e.g., 81410, 81430, 81455–81459) are assigned to Carelon and require preauthorization/review under Carelon categories such as Hereditary Cancer Testing, Somatic Tumor Testing, Carrier Screening, Pharmacogenetic Testing, and Whole Exome/Genome Sequencing.

    • Single‑gene and gene‑analysis CPT examples: 81120, 81121, 81161, 81252–81257, 81335, 81336
    • Molecular pathology Level codes 81400–81408 assigned to Carelon
    • Genomic panel examples requiring review: 81410, 81430, 81455–81459
    Prior Authorization

    Selected Single‑Gene and Gene‑Analysis CPT Codes

    Selected single‑gene and gene‑analysis CPT examples are listed and require Carelon review prior to testing; these include, but are not limited to, TPMT (81335), SMN1 (81336–81337), BRCA1/BRCA2 analyses (81162–81167), and various carrier screening gene analyses (81252–81256).

    • Examples: TPMT 81335 (pharmacogenetic); SMN1 81336–81337 (SMA testing); BRCA1/2 81162–81167 (hereditary cancer testing)
    • Providers must obtain Carelon prior authorization per genetic testing criteria
    Prior Authorization

    Molecular Oncology Panels (Examples)

    Large molecular oncology/genomic panels (e.g., 81455–81459, 81462–81464) and other somatic tumor testing panels require Carelon prior authorization and are reviewed under Somatic Tumor Testing or Genetic Liquid Biopsy guidelines. These panels often have minimum gene counts and specific criteria for clinical use.

    • Molecular oncology panel examples: 81455–81459 (51+ gene panels) assigned to Carelon
    • Cell‑free and liquid biopsy panels (81462–81464) reviewed under Genetic Liquid Biopsy guidance
    Prior Authorization

    Reproductive Technology and Storage

    Assisted reproductive technology and related services (e.g., assisted oocyte fertilization 89281, embryo biopsy 89290–89291, cryopreservation 89337, storage codes 89344/89346, thawing 89354/89356) require prior authorization and are managed by Carelon under Fertility and ART clinical criteria (CG‑MED references).

    • Fertility/ART codes (89281, 89290–89291, 89337, 89344, 89346, 89354, 89356) assigned to Carelon
    • Carelon applies CG‑MED and program‑specific criteria for ART and storage services
    Prior Authorization

    Speech/Language Therapy Services

    Speech/language pathology evaluation and treatment codes (e.g., 92507–92508 for treatment, 92521–92524 evaluations, 92526 swallowing therapy, augmentative device evaluation 92605–92608, 92609–92611) are subject to Carelon review and prior authorization under Physical Therapy/Occupational Therapy/Speech Therapy program criteria and Site of Care guidance.

    • SLP treatment and evaluation codes (92507–92508, 92521–92526) require Carelon review
    • Augmentative and alternative communication device evaluation/training (92605–92609) mapped to Carelon therapy guidelines
    Prior Authorization

    Percutaneous Coronary Interventions

    Percutaneous coronary interventions (PCI) and related coronary procedure codes (e.g., 92920, 92924, 92928, 92933, 92937, 92943, 92972) require prior authorization and are reviewed by Carelon under the Percutaneous Coronary Intervention program and applicable MCG ISC/GRG guidance.

    • PCI codes (92920, 92924, 92928, 92933, 92937, 92943, 92972) assigned to Carelon
    • Carelon applies MCG Percutaneous Coronary Intervention criteria
    Prior Authorization

    Cardiac Imaging and Device Services

    Cardiac imaging, device services and monitoring codes (e.g., pacemaker/ICD implantation/replacement 33206–33227, device interrogation/programming 93150–93153, transthoracic/transesophageal echocardiography 93303–93317/93350–93351) are managed by Carelon and reviewed under Imaging of the Heart, Permanent Implantable Pacemakers and related Cardiac Device criteria.

    • Permanent pacemaker/device implantation and revision codes (33206–33227) require Carelon review
    • Device interrogation/programming and echocardiography codes (93150–93153, 93303–93317, 93350–93351) assigned to Carelon
    Prior Authorization

    Echocardiography Prior Authorization

    Echocardiography codes (transthoracic and transesophageal; rest and stress studies — e.g., 93306–93308, 93312–93317, 93350–93351) are assigned to Carelon and reviewed using Imaging of the Heart criteria. Prior authorization is required when indicated by the member's benefits and Carelon guidelines.

    • TTE/TEE and stress echo codes (93306–93308, 93312–93317, 93350–93351) mapped to Imaging of the Heart
    • Obtain Carelon prior authorization when required by benefit plan
    Prior Authorization

    Coronary Angiography Prior Authorization

    Diagnostic coronary angiography and left/right heart catheterization codes (e.g., 93454–93461, 93458–93460) require prior authorization and are reviewed by Carelon using Diagnostic Coronary Angiography and MCG guidance. Ensure preapproval is obtained when required.

    • Coronary angiography catheterization codes (93454–93461, 93458–93460) assigned to Carelon
    • Carelon applies MCG Diagnostic Coronary Angiography criteria
    Prior Authorization

    Electrophysiology / Ablation Prior Authorization

    Electrophysiology study and ablation codes (e.g., 93600–93624, 93650, 93653–93657) are managed by Carelon and reviewed using Electrophysiological Studies and Ablation MCG guidelines. Prior authorization is required for EP studies and ablations when indicated.

    • EP study and ablation codes (93600–93624, 93650, 93653–93657) assigned to Carelon
    • Carelon references MCG Electrophysiological Studies and Ablation guidelines
    Prior Authorization

    Vascular Imaging Prior Authorization

    Vascular imaging (duplex, CTA, physiologic studies) and noninvasive arterial studies (codes 93880–93882, 93922–93931, 93923–93926) are assigned to Carelon and reviewed under Vascular Imaging criteria. Prior authorization is required when indicated by benefit design and Carelon policies.

    • Duplex vascular scan and physiologic study codes (93880–93882, 93922–93931) mapped to Vascular Imaging
    • Providers should obtain Carelon preauthorization for vascular imaging when required
    Prior Authorization

    Respiratory / Sleep Study Prior Authorization

    Respiratory and sleep study codes (polysomnography, unattended sleep testing, MSLT) such as 95782–95783, 95800–95811, and related service codes are reviewed by Carelon under Sleep Disorder Management. Obtain prior authorization for sleep testing and therapy when required.

    • Sleep study and polysomnography codes (95782–95783, 95800–95811) assigned to Carelon
    • Carelon applies Sleep Disorder Management criteria for prior authorization
    Prior Authorization

    Neuro / Function Imaging Prior Authorization

    Neuro/function imaging and specialized functional testing (e.g., autonomic testing 95921–95923, MEG 95965–95967, motion analysis 96001) are reviewed by Carelon under Imaging of the Brain and related functional imaging criteria. Prior authorization is required when indicated.

    • Autonomic testing codes (95921–95923) mapped to specific MED policies
    • MEG codes (95965–95967) and motion analysis (96001) assigned to Carelon
    Prior Authorization

    PT / OT / SLP Services Prior Authorization

    Physical, occupational and speech therapy services (PT/OT/SLP) including evaluation and established plan codes (97110 therapeutic exercise; 97112 neuromuscular reeducation; 97113 aquatic therapy; 97116 gait training; 97124 massage; 97129/97130 cognitive therapy; 97140 manual therapy; evaluation/re-evaluation codes 97161–97164, 97165–97168; activity/device codes 97530–97763) require review and prior authorization by Carelon under Rehabilitative Services and Site of Care for Therapies policies.

    • Therapeutic exercise 97110 and related modalities (97010–97036, 97032–97035) mapped to Carelon therapy criteria
    • Therapy evaluations (97161–97164 PT; 97165–97168 OT) and cognitive/manual/group therapy codes require Carelon review
    • Activity/device and work conditioning codes (97530, 97533, 97535, 97542, 97545–97546, 97750–97763) assigned to Carelon
    Prior Authorization

    Therapeutic Exercise (97110)

    Therapeutic exercise code 97110 (therapeutic exercises to develop strength, endurance, ROM and flexibility; each 15 minutes) is assigned to Carelon and requires prior authorization per the Physical Therapy program criteria and Site of Care guidance.

    • 97110 requires Carelon review under Physical Therapy criteria
    • Document therapy frequency, duration, and functional goals when submitting prior authorization requests
    Prior Authorization

    Various Therapy Modalities

    Various therapy modalities (neuromuscular reeducation 97112, aquatic therapy 97113, gait training 97116, massage 97124, cognitive therapy 97129/97130, manual therapy 97140, group therapy 97150) and assistive device/orthotic/prosthetic management codes (97750–97763) are managed by Carelon and require prior authorization when indicated.

    • Neuromuscular reeducation (97112), aquatic therapy (97113), gait training (97116) require Carelon review
    • Orthotic/prosthetic management and assistive device training (97750–97763) assigned to Carelon
    Prior Authorization

    Therapy Cognitive / Manual / Group / Evaluation Codes

    Cognitive, manual, group and evaluation codes for therapy (97129–97130 cognitive interventions; 97140 manual therapy; 97150 group therapy; evaluation/re-evaluation series 97161–97168) require Carelon prior authorization and must include documentation of functional deficits, treatment goals, and expected duration.

    • Include measurable functional goals and justification when requesting authorization for cognitive/manual/group therapies
    • Therapy evaluation codes (97161–97164 PT; 97165–97168 OT) mapped to Carelon review
    Prior Authorization

    Therapy Activity and Device‑Related Codes

    Therapy activity and device‑related codes (e.g., therapeutic activities 97530, wheelchair management 97542, work hardening 97545–97546, assistive technology assessment 97755) require prior authorization under Carelon's Physical/Occupational Therapy and device management criteria. Provide assessment details and measurable objectives when requesting authorization.

    • Therapeutic activities and device assessments (97530, 97542, 97755) assigned to Carelon
    • Work hardening and conditioning codes (97545–97546) require Carelon review and documentation of work‑related goals
    Prior Authorization

    Genetic and Somatic Testing PLA Codes

    Molecular pathology PLA/unique laboratory (0001U– and other PLA/unique codes) and numerous genetic/somatic testing PLA codes listed in this document are assigned to Carelon for prior authorization and are reviewed under the applicable Carelon genetic and somatic testing criteria (Somatic Tumor Testing, Hereditary Cancer Testing, Pharmacogenetic Testing, Whole Exome/Genome Sequencing, Genetic Liquid Biopsy, etc.).

    • PLA/unique molecular oncology and liquid biopsy codes (0001U, 0006M, 0011M, 0012M, 0016M–0017M, 0019U–0020M, etc.) assigned to Carelon
    • Carelon review required for novel/PLA molecular tests with linkage to Somatic Tumor Testing or Genetic Liquid Biopsy guidance
    Prior Authorization

    Genetic and Somatic Testing Codes (Excerpt)

    An excerpt of genetic and somatic testing codes (examples) are included for provider awareness; these codes are reviewed by Carelon and mapped to specific Carelon criteria such as Carrier Screening, Hereditary Cancer Testing, Somatic Tumor Testing, Pharmacogenetic Testing, and Whole Exome/Genome Sequencing. Obtain preauthorization per Carelon processes.

    • Examples include 0048U (large cancer panel), 0055U (heart transplant cfDNA), 81162–81167 (BRCA analyses), 81455–81459 (large somatic panels)
    • Providers should submit requested clinical information consistent with the applicable Carelon criteria
    Prior Authorization

    Additional Genetic / Testing Codes

    Additional genetic and testing codes (multiple U‑codes, PLA codes and conventional CPTs across hereditary, pharmacogenetic, and somatic testing) are assigned to Carelon and require prior authorization. Review Carelon criteria for test‑specific documentation requirements before ordering.

    • Additional examples: 0016U, 0017U, 0022U, 0026U, 0036U, 0037U, 0046U
    • Carelon may require clinical indication, prior treatments, pathology reports, and prior test results when authorizing advanced genetic testing
    Prior Authorization

    Predictive, WES/WGS, and Surgical Codes

    Predictive tests, whole exome sequencing (WES)/whole genome sequencing (WGS), and certain surgical T‑codes or novel procedure codes are assigned to Carelon and reviewed under Predictive/Prognostic testing, WES/WGS criteria, or relevant surgical MCG guidance. Examples include WES/WGS panels (81425–81427, 81460, 81465), predictive polygenic tests, and specialized surgical T‑codes (e.g., 0095T, 0164T, 0169U).

    • WES/WGS and related codes (81425–81427, 81460, 81465) assigned to Carelon
    • Predictive polygenic tests and specialized surgical T‑codes require test‑specific Carelon review
    Prior Authorization

    Hereditary and Somatic Testing Codes

    Hereditary cancer and somatic tumor testing codes (including many panel, sequence and copy number tests, e.g., 81162–81167, 81432, 81455–81459, 81462–81464, 0101U–0103U, 0129U) are assigned to Carelon and reviewed under Hereditary Cancer Testing and Somatic Tumor Testing criteria. Preauthorization and required clinical documentation are determined per Carelon guidelines.

    • Hereditary cancer panels (e.g., 81162–81167, 81432, 0101U–0103U) and somatic tumor panels (81455–81459, 81462–81464) require Carelon review
    • Providers should supply family history, tumor pathology, and prior testing when requested
    Note

    Mixed Genetic and Procedure Codes

    Mixed lists of genetic and procedure codes in this document indicate Carelon responsibility for both diagnostic/procedural prior authorization and genetic test review. For combined procedures (e.g., image‑guided interventions with molecular testing), follow Carelon submission processes and include all pertinent clinical and imaging/pathology documentation.

    • When procedures and genetic tests are ordered together, submit both clinical and diagnostic documentation to Carelon
    • Mixed code sets include interventional, imaging, surgical and genetic testing codes mapped to corresponding Carelon criteria
    Prior Authorization

    Polygenic, Pharmacogenetic, Cytogenomic, and Interventional Codes

    Polygenic, pharmacogenetic, cytogenomic, and interventional molecular codes (e.g., 81418, 81419, 81335, 81381, 0036U, 0037U, 0070U–0076U, 0029U–0031U) are assigned to Carelon and require review under Pharmacogenetic Testing, Predictive and Prognostic Polygenic Testing, Chromosomal Microarray and Somatic testing criteria.

    • Pharmacogenetic and polygenic panels (81418, 81419) assigned to Carelon
    • CYP2D6 and related pharmacogenetic U‑codes (0070U–0076U, 0031U) require specific review/documentation
    Prior Authorization

    WES/WGS, Interventional, and Remaining Genetic Codes

    Final entries including WES/WGS, interventional genetics, and remaining genetic codes (e.g., 0212U, 0213U, 0214U, 0215U, 0216U, 0217U, 0218U and other U‑codes listed) are reviewed by Carelon under the Whole Exome/Genome Sequencing, Genetic Testing for Inherited Conditions, and related Carelon clinical criteria. Obtain preauthorization per Carelon submission instructions.

    • WES/WGS and rare disease genome codes (0212U, 0213U, 0214U) assigned to Carelon
    • Interventional and paravertebral facet ultrasound guidance T‑codes (0213T–0218T) mapped to Interventional Pain Management and Carelon review
    VerificationProviders will be notified upon requesting precertification if preapproval is required for the member
    Responsible party — Carelon accountable for prior authorization review and applying MCG/internal guideline references
    Accountable organizationCarelon Medical Benefits Management is accountable for prior authorization review and applying cited MCG/internal guideline references to listed CPT codes
    ResponsibilitiesConduct clinical review, apply criteria/guidelines, and render precertification decisions for assigned service categories
    Contact for requestsProviders submit preapproval requests via Carelon portal or phone per document instructions
    Criteria/Guideline — clinical reference (MCG, ISC, GRG, RRG) informing coverage decisions
    DefinitionCriteria/Guideline = the clinical reference (eg, MCG, ISC, GRG, RRG, RFC) that informs coverage decisions for a specific procedure code
    ExamplesMCG 'Spine Surgery', 'Joint Surgery', 'Imaging of the Heart', and Carelon internal guideline categories
    ApplicationRefer to the named guideline assigned to each code when determining medical necessity and authorization
    Responsible party — Carelon accountable for review and authorization determinations
    Review authorityCarelon Medical Benefits Management is the responsible party for review and authorization determinations for listed procedures
    Guideline integrationCarelon applies MCG and internal guideline categories (eg, Joint Surgery, Spine Surgery) during review
    Per-code assignmentEach CPT entry includes a responsible party and criteria/guideline designation used in authorization
    MCG Guidelines — external clinical guidance referenced for level-of-care and procedure-specific criteria
    MCG referenceMCG Guidelines are the external clinical guidance referenced for level-of-care and procedure‑specific criteria
    Use in documentMCG ISC/RFC/RRG identifiers are cited alongside Carelon criteria for many surgical and imaging codes
    ExamplesISC: S-700 (Knee Arthroplasty), ISC: S-340 (Cervical Laminectomy) appear in entries
    MCG Guidelines (term) — referenced explicitly in document
    Term usageMCG Guidelines (term) — referenced explicitly as the clinical guideline source for many entries
    IntegrationUsed with Carelon criteria to define Level of Care and Site of Care decisions
    NotationMCG identifiers (ISC/GRG/RRG) are provided per code where applicable
    GRG specialty group/resource guidelines — example GRG: SG-CVS
    DefinitionGRG = specialty Group/Resource Guidelines (examples: SG-CVS for cardiovascular surgery)
    RoleGRGs are used to classify procedure groups when assigning criteria/guideline references
    ExampleSG‑CVS cited for varicose vein and cardiovascular procedures
    Carelon Medical Benefits Management — responsible party definition repeated
    Responsible party (repeat)Carelon Medical Benefits Management — the organization designated to review and manage precertification/prior authorization decisions
    Scope of servicesManages Advanced Imaging, Genetic Testing, Radiation Therapy, Musculoskeletal, Oncology Drugs, Fertility, Rehabilitative Services, and others listed
    Provider submissionRequests via www.providerportal.com (select GA) or call 866-714-1103
    Carelon guidelines and MCG references — criteria/guideline references across specialties
    Guideline references across specialtiesCarelon criteria and MCG guideline identifiers (eg, Carrier Screening, Somatic Tumor Testing, Imaging of the Heart) cited for multiple specialty areas
    Cross-reference practiceEach code entry pairs a responsible party (Carelon) with the applicable Carelon/MCG guideline category
    ImplicationConsult the named Carelon guideline for indication‑specific medical necessity criteria
    Carelon is responsible for review/authorization decisions for listed codes — reiterated
    Reviewer responsibility (reiterated)Carelon is responsible for review and authorization decisions for the listed codes (imaging, surgical, and other procedures)
    MCG linkageWhere indicated, MCG guideline identifiers accompany Carelon criteria to inform level/site-of-care decisions
    Provider actionProviders must obtain precertification when required; failure risks denial (document-wide instruction)
    Clinical guidance referenced — Carelon criteria and MCG guideline identifiers (ISC, RFC, GRG, CG-SURG)
    Clinical guidance examplesCarelon criteria and MCG guideline identifiers such as ISC, RFC, GRG, CG-SURG are used as clinical references for authorization
    Per-code annotationCodes include Criteria/Guideline fields indicating which guideline to consult during review
    Decision supportThese references guide clinical necessity determinations rather than replace clinical judgment
    Responsible party for review and authorization determinations — Carelon for advanced imaging and other codes
    Reviewer for advanced imagingCarelon Medical Benefits Management reviews advanced imaging codes and applies 'Site of Care for Advanced Imaging' and body-region imaging guidelines
    ExamplesImaging of the Brain, Imaging of the Spine, Imaging of the Chest, Imaging of the Abdomen and Pelvis are named criteria referenced per code
    ActionPrior authorization is required or managed per those guidelines for the listed imaging CPTs
    Criteria/Guideline — internal named guideline used to evaluate medical necessity
    DefinitionCriteria/Guideline = the named internal or external guideline used to evaluate medical necessity or site-of-care for a specific code
    Common imaging criteriaSite of Care for Advanced Imaging; Imaging of the Brain; Oncologic Imaging; Vascular Imaging; Imaging of the Spine
    ApplicationApply the guideline listed with the code when adjudicating precertification requests
    Responsible party — review/apply criteria for listed cardiac imaging codes (Carelon)
    Assigned reviewerCarelon Medical Benefits Management is the designated entity to review and apply criteria/guidelines for the listed cardiac imaging codes
    Cardiac imaging guideline'Imaging of the Heart' is the applicable Carelon guideline for many cardiac MRI/CT and echocardiography CPTs
    ResultPrior authorization required or managed per the named guideline
    Criteria/Guideline — named internal guideline(s) that apply to codes for authorization
    Named internal guidelinesExamples include 'Imaging of the Heart' and 'Radiation Therapy (excludes Proton)' which apply to specific codes for authorization decisions
    Use per codeCodes list the applicable guideline(s) to be referenced during care review (eg, Diagnostic Coronary Angiography; Transcatheter Ablation)
    Decision effectGuideline assignment determines criteria applied to precertification and medical necessity reviews
    Responsible party — Carelon MBM as reviewer for genetic testing codes
    Genetic testing reviewerCarelon Medical Benefits Management is the reviewer/criteria owner for listed genetic testing codes
    Guideline categoriesGenetic testing CPTs are assigned Carelon categories such as Hereditary Cancer Testing, Carrier Screening, Somatic Tumor Testing
    Provider implicationSubmit genetic test precertification requests to Carelon and reference the assigned guideline category
    Criteria/Guideline — Carelon policy category used to determine medical necessity for genetic testing
    Carelon policy categoriesCarelon policy categories (eg, Hereditary Cancer Testing; Carrier Screening in the Reproductive Setting; Somatic Tumor Testing) are used to determine medical necessity for genetic tests
    Per-code guidanceEach genetic CPT lists the applicable Carelon guideline category to consult for authorization criteria
    Examples81161–81167 entries show 'Hereditary Cancer Testing' and 'Carrier Screening' associations
    Responsible party reiterated — Carelon Medical Benefits Management
    Carelon (reiterated)Carelon Medical Benefits Management — responsible party for many listed service categories throughout the document
    ScopeManages utilization and precertification across imaging, surgical, genetic, and therapy services per assigned guidelines
    ContactProvider portal and phone contact instructions included in header section
    Somatic Tumor Testing — defined category
    Somatic Tumor Testing categoryDefined as the Carelon guideline category applied to somatic tumor genomic tests (eg, 81455, 0211U, PLA codes) for authorization
    ApplicationUsed to evaluate oncology molecular panels, expression assays, and cell‑free (liquid biopsy) tests
    Example codes81455, 0211U, 0046U referenced under Somatic Tumor Testing
    Hereditary Cancer Testing — defined category
    Hereditary Cancer TestingCarelon category applied to hereditary cancer gene analyses and panels (eg, BRCA1/2 entries 81161–81167)
    UseConsult Hereditary Cancer Testing guideline for medical necessity and prior authorization of hereditary cancer panels
    Representative codes81161–81167 and panels such as 81432 are assigned to this category
    Pharmacogenetic Testing — defined category
    Pharmacogenetic TestingCarelon category for drug‑metabolism and pharmacogenomic gene analyses (eg, CYP and TPMT entries)
    Representative codes81230–81233, 81328, 81335, 81418 and others mapped to Pharmacogenetic Testing
    PurposeUsed to guide authorization of pharmacogenetic single‑gene tests and panels
    Molecular pathology procedure levels — Level 1-9 defined
    Molecular pathology levelsMolecular pathology procedure levels (Level 1–9) are defined for CPT 81400–81408 and related codes
    ExamplesLevels describe complexity (eg, Level 1 single variant methods to Level 6–9 multi‑exon or multi‑gene sequencing panels)
    Use in reviewCarelon applies these molecular pathology levels with appropriate guideline categories for coverage decisions
    Whole Exome/Genome Sequencing — defined term and example codes
    WES/WGS definitionWhole Exome/Genome Sequencing referenced for exome/genome analyses and related comparator/re‑evaluation descriptors (eg, 81426, 81427 entries)
    ApplicationUsed for evaluation of unexplained constitutional/heritable disorders and re-evaluation of previously obtained genome results
    Example codes81425–81427 and PLA WES/WGS entries (0094U, 0212U) referenced to this category
    Whole mitochondrial genome — definition per 81460 description
    Whole mitochondrial genomeDefined as genomic sequence analysis of the entire mitochondrial genome with heteroplasmy detection (per 81460 description)
    Representative code81460 is listed with this definition and reviewed by Carelon under WES/WGS guidance
    Related entries81465 (large deletion analysis) also references whole exome/genome guideline categories
    Genetic Liquid Biopsy — definition for cell-free genomic analysis panels
    Genetic Liquid BiopsyCell‑free (plasma) genomic sequence analysis panels (eg, 81462–81464) reviewed under 'Genetic Liquid Biopsy in the Management of Cancer and Cancer Surveillance' guideline
    Use caseApplied to somatic tumor testing and surveillance via plasma cell‑free assays
    Representative codes81462–81464, 0229U referenced to this guideline
    Responsible party — Carelon for cardiac/imaging review entries
    Cardiac/imaging review responsibilityCarelon Medical Benefits Management is responsible for review and prior authorization of cardiac imaging and related procedures
    Guideline examplesImaging of the Heart; Diagnostic Coronary Angiography; Transcatheter Ablation (MCG) are applied per code
    Provider actionSubmit imaging precertification requests to Carelon; consult the listed guideline for authorization criteria
    Criteria/Guideline — named internal/external guidelines for cardiac/imaging codes
    Applicable criteria/guidelinesNamed internal/external guidelines (eg, Imaging of the Heart; Diagnostic Coronary Angiography; Vascular Imaging) inform coverage for cardiac and vascular codes
    Code-level mappingEach cardiac/vascular CPT includes a Criteria/Guideline field indicating which guideline to apply
    Decision implicationUse that guideline when determining medical necessity for precertification decisions
    97161 — PT evaluation low complexity definition
    97161 definitionPhysical therapy evaluation, low complexity — typically 20 minutes face-to-face; history with no personal factors/comorbidities; exams addressing 1–2 elements; low complexity decision making
    Responsible partyCarelon Medical Benefits Management applies PT/OT/ST guidelines when reviewing these evaluations
    UsageMap 97161 to low complexity evaluation expectations for authorization purposes
    97163 — PT evaluation high complexity definition
    97163 definitionPhysical therapy evaluation, high complexity — typically 45 minutes face-to-face; history with 3+ personal factors/comorbidities; exams addressing 4+ elements; high complexity decision making
    ApplicationMap 97163 to high-complexity criteria when requesting or reviewing authorization
    ReviewerCarelon applies PT/OT/ST guideline categories to these evaluations
    Responsible party reiterated — Carelon MBM for remaining code sections
    Carelon responsibility (final)Carelon Medical Benefits Management is the organization assigned to review and manage authorization criteria for the remaining listed codes
    ScopeIncludes genetic panels, WES/WGS entries, PLA codes, and interventional procedure codes in the final segments
    Reference guidanceConsult the Carelon guideline assigned to each code for detailed medical necessity criteria
    MCG — clinical guideline source used for some surgical/procedure code criteria
    MCG definitionMCG is the referenced clinical guideline source used in this document for surgical/procedure code criteria and level-of-care determinations
    Examples of useMCG ISC/RRG/GRG identifiers accompany many surgical and procedural CPTs to define applicability
    IntegrationCarelon applies MCG guidance alongside internal Carelon criteria during prior authorization reviews